The FirePlex®Discovery Panels profile the expression of 405 miRNAs found in circulating biofluids.This product specifically focuses on rodent-specific miRNAs. These miRNAs have beenselected based on a detailed study of data in peer-reviewed journals and are differentially regulated in whole blood, plasma, serum, peripheral blood mononuclear cells (PBMCs) isolated exosomes.
NOTE: FirePlex miRNA panels require the purchase of a Run Buffer. Use ourFirePlex Cytometer Setup Kit V2 (ab245835)to select the most appropriate Run Buffer for your flow cytometer.
Our multiplex assays use FirePlex®particle technology to profile 405 miRNAs in each sample. With the same sensitivity as PCR, they can be used either directly with crude serum or plasma with no need for RNA purification and as little as 100 µL of sample; or with less than7 ng of purified RNA.
Find a full list of validated sample types, and learn more about the performance and requirements of these assays,here.
The 12 test selling size provides the required volume of reagents for analyzing 12 independent biological samples, as well as positive and negative controls.
The48 test selling size provides the required volume of reagents for analyzing 48 independent biological samples, as well as positive and negative controls.
In addition to the FirePlex miRNA Assay V2 - Human Discovery Panels, customers must purchase the corresponding FirePlex miRNA Assay Core Reagent Kit V2 for their specific sample type, as follows: Purified RNA (ab218365), Biofluids (ab218342), or FFPE/Tissues (ab235025)
FirePlex®is a registered trademark in the United States and an unregistered trademark elsewhere.
Please see the discovery panels listhere.
Components | 12 tests | 48 tests |
---|---|---|
FirePlex miRNA Assay V2 Discovery Panel Particle Mix | 8 x 500µl | 8 x 2000µl |
Abcam 位于英国的剑桥科学园,成立于1998年,专门生产和分销研究型抗体。在线目录 (www.abcam.cn) 已有超过 120,000 种抗体和试剂,并不断添加,供应予全球百多个国家。
为使研究员更容易找到蛋白质研究试剂产品,在2011并购了美国的 MitoSciences 公司,加强了免疫分析方面的产品供应;同年也并购了英国的 Ascent Scientific 公司,开展了生化试剂的供应。在2012年并购了美国的 Epitomics 公司,成为一家有领导地位的 RabMAbs® 供应商。
Abcam 的目标是给世界上最好的抗体建立最大的在线目录,为各地科学家提供尖端产品,成为各国科学界的重要伙伴,为所有产品提供技术支持来使客户获得预期的结果,为提供高质量的抗体来指向尽可能多的靶蛋白,尽所能在尽可能多的应用和物种中检测每种抗体。
Abcam 专注于特定的研究领域,包括肿瘤研究、心血管研究、染色质和基因调控研究、免疫学、内参对照、微生物学、神经科学、细胞核信号转导研究、RNAi 研究、干细胞研究、亚细胞标记物等。